disease-signature

Integrative transcriptome-based drug repurposing in tuberculosis

Tuberculosis (TB) remains the second leading cause of infectious disease mortality worldwide, killing over one million people annually. Rising antibiotic resistance has created an urgent need for host-directed therapeutics (HDTs) — preferably by …

Computational approaches to study molecular pathogenesis and intervention of infectious diseases

Reconciling Multiple Connectivity Scores for Drug Repurposing

The basis of several recent methods for drug repurposing is the key principle that an efficacious drug will reverse the disease molecular 'signature' with minimal side effects. This principle was defined and popularized by the influential …

Host respones and therapeutic interventions

Computational approaches to study host responses to infection and identify host-directed therapeutic interventions.